WO2015192433A1 - Process for synthesizing (r)-1-(naphthalene-1-group) ethylamine - Google Patents

Process for synthesizing (r)-1-(naphthalene-1-group) ethylamine Download PDF

Info

Publication number
WO2015192433A1
WO2015192433A1 PCT/CN2014/082413 CN2014082413W WO2015192433A1 WO 2015192433 A1 WO2015192433 A1 WO 2015192433A1 CN 2014082413 W CN2014082413 W CN 2014082413W WO 2015192433 A1 WO2015192433 A1 WO 2015192433A1
Authority
WO
WIPO (PCT)
Prior art keywords
mixture
solvent
azide
naphthalene
chloride
Prior art date
Application number
PCT/CN2014/082413
Other languages
French (fr)
Chinese (zh)
Inventor
黄志鸿
徐亮
李彦雄
马卡⋅穆罕默德
Original Assignee
中山奕安泰医药科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中山奕安泰医药科技有限公司 filed Critical 中山奕安泰医药科技有限公司
Publication of WO2015192433A1 publication Critical patent/WO2015192433A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/30Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
    • C07C209/42Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitrogen-to-nitrogen bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Definitions

  • the present invention belongs to the field of pharmaceutical intermediates, and is mainly related to the novel process of 1 (naphthalene 1 -yl)ethylamine.
  • Cinacalcet hydrochloride (trade name Sensipar) was developed by NFS Ptarmaeeiiticals in the United States. It was approved by the FDA in March 2004. The main symptoms of the disease are: 1) Treatment of sputum Xieman's disease (CKD) "Kids see” secondary hyperparathyroidism; 2" treatment of hyperparalemia in patients with parathyroid cancer, its ft mechanism is activated in the parathyroid gland " « receptor, from Li hypoparathyroid ( PTH “curve” ; regulates the behavior of parathyroid calcium receptors, by increasing the sensitivity of receptors to calcium levels in the bloodstream, reducing levels of parathyroid hormone, calcium, phosphorus and calcium-phosphorus complexes.
  • CKD sputum Xieman's disease
  • PTH Li hypoparathyroid
  • the ft component of cinacalcet hydrochloride, Ciiwealcct, ft, N-((LR) 1-(1-naphthyl)ethyl)-3-(3-(trifluoromethyl) Phenyl)-l-amine Dmgs 2002, 27(9), 8311 83 discloses a method for preparing cinacalcet, and the main route is as follows:
  • J. Org. Chem., 2013, 78 (11), 5314-5327 also discloses a method for synthesizing (R)-l-(naphthalen-1-yl)ethylamine, which is synthesized as follows:
  • An object of the present invention is to provide a novel process for synthesizing (R)-l ⁇ (naphthalen-1-yl)ethylamine which is inexpensive and of good product quality.
  • the solvent is used to dissolve anhydrous 1-naphthyl ethyl ketone and degassed by argon gas, and the molar ratio to anhydrous 1-naphthylethyl ketone is
  • catalyst ⁇ preferably (5, 5)-DIOPRuCl 2 (5)-Me-BIMAH, added to the base with a molar ratio of anhydrous 1-naphthyl ethyl ketone of 20/1 ⁇ 30/1 C, charged with 8 ⁇ 30 bar of hydrogen, stirred at 0 ⁇ 50 °C for 8-16 h; filtered, solvent was removed to give off-white solid (naphthalen-1-yl) ethanol (II);
  • the catalyst A described in the step (1) is a BIMAH ligand and a dichlorophenyl ruthenium (II) complex produced by a phosphorus ligand such as DIOP, BI AP Josiphos, etc., and Zhongshan Aantai Pharmaceutical Technology Co., Ltd.
  • the solvent B in the step (1) is any one or more of benzene, toluene, o-xylene, p-xylene, tert-butanol, isopropanol, ethanol, methanol, and acetonitrile. a mixture, preferably a mixed solvent of toluene and tert-butanol;
  • the base C in the step (1) is a mixture of any one or more of potassium t-butoxide, sodium t-butoxide, cesium carbonate, potassium carbonate, sodium ethoxide, and sodium amide. Potassium tert-butoxide.
  • the hydrogen pressure in step (1) is 8 to 30 bar, preferably 30 bar.
  • the solvent D described in the step (2) is a mixture of any one or more of toluene, tetrahydrofuran, dichloromethane, N, N-dimethylformamide, chloroform, preferably dichloro Hyperthyroidism.
  • the acid binding agent E in the step (2) is triethylamine, diisopropylethylamine, pyridine, N, N-lutidine, potassium carbonate, cesium carbonate, sodium carbonate,
  • a mixture of any one or more of magnesium carbonate, potassium hydroxide and sodium hydroxide is preferably triethylamine.
  • the sulfonyl chloride derivative F according to the step (2) is a mixture of any one or more of methylsulfonyl chloride, trifluoromethylsulfonyl chloride, p-toluenesulfonyl chloride, and benzenesulfonyl chloride.
  • methylsulfonyl chloride is used.
  • the ratio of the (5)-1-(naphthalen-1-yl)ethanol (II) to the sulfonyl chloride derivative F in the step (2) is from 1/1 to 1/10, preferably. 1/1.5.
  • the anhydrous solvent G in the step (3) is dimethyl sulfoxide, N, N-dimethylformamide, acetone, nitromethylpyrrolidone, tetrahydrofuran, acetonitrile. Mixture of any one or more, preferably dimethyl sulfoxide.
  • the azide H of the step (3) is a mixture of any one or more of sodium azide, lithium azide, potassium azide, and diphenyl azide. , sodium azide is preferred.
  • the catalyst I described in the step (4) is a palladium-containing catalyst or a nickel-containing catalyst, which is 20% Pd/C, 10% Pd/C, 5% Pd/C, 10% Pd (OH).
  • splitting step is avoided, waste is avoided, and the cost is lower.
  • step (3) In a 50 mL hydrogenation tube, dissolve 0.8 g of light yellow oil obtained in step (3) in 20 mL of methanol, add 70 mg of 20%, charge 1 bar of hydrogen, and stir at 25 °C. 24 h. Filtration, the solvent was evaporated to give a pale-yellow oil, and a crude over-alloyed alumina column yielded 0.56 g of a yellow oil with a yield of 80.4% and an ee value of 93%.
  • step (3) Dissolve 0.8 g of light yellow oil obtained in step (3) in 20 mL of methanol in a 50 mL hydrogenation tube, add 60 mg of Raney nickel, and charge 1 bar of hydrogen at 25 °C. Stir for 24 h. Filtration, the solvent was evaporated to give a pale-yellow oil, and the crude over-alloyed alumina column yielded 0.65 g of a yellow oil with a yield of 93.3% and an ee value of 94%.

Abstract

Provided is a process for synthesizing (R)-1-(naphthalene-1-group) ethylamine (I). The process comprises: using 1-acetonaphthone as a starting raw material; reducing the 1-acetonaphthone to (S)-1-(naphthalene-1-group) ethanol (II) by means of asymmetric hydrogenation, and then obtaining (R)-1-(naphthalene-1-group) ethylamine (I) with a high ee value after formation of (S)-1-(naphthalene-1-group) NOEPES derivative (III), azidation (IV) and hydrogenation reduction. The process has the characteristics of being easy to obtain raw materials and low in costs, and the like.

Description

—豨合慮, - 基 嶋工¾ 貧术領域  - 豨 虑 , - 基 嶋 3 3⁄4
本发明属于医药 工中间体合 Λ領域, 主要涉 Λ—种合慮 ( 1 (萘 1基)乙胺 新工艺。 背景技术  The present invention belongs to the field of pharmaceutical intermediates, and is mainly related to the novel process of 1 (naphthalene 1 -yl)ethylamine.
盐酸西那卡塞 (商品名 Sensipar)是由美国 NFS Ptarmaeeiiticals公 研发 , 经 FDA于 2004年 3月 8 U批准上市, 其主要适盧症为: 1 ) 治疗纖行透祈謝曼性肾病 (CKD)患 看》继发性甲状旁腺功能 Λ进症; 2》治疗甲状旁腺癌患者的高 血症 其 ft用机制为激活甲 状旁腺中》«受体, 从丽 低甲状旁腺素 (PTH》曲分《; 调节甲状旁腺钙受体 行为,通过增 ¾受体对血流中钙水平的敏感性, 降低甲状旁腺激素、 钙、 磷和钙 -磷复合物 «水平。 Cinacalcet hydrochloride (trade name Sensipar) was developed by NFS Ptarmaeeiiticals in the United States. It was approved by the FDA in March 2004. The main symptoms of the disease are: 1) Treatment of sputum Xieman's disease (CKD) "Kids see" secondary hyperparathyroidism; 2" treatment of hyperparalemia in patients with parathyroid cancer, its ft mechanism is activated in the parathyroid gland "« receptor, from Li hypoparathyroid ( PTH "curve"; regulates the behavior of parathyroid calcium receptors, by increasing the sensitivity of receptors to calcium levels in the bloodstream, reducing levels of parathyroid hormone, calcium, phosphorus and calcium-phosphorus complexes.
盐酸西那卡塞的 ft性成分西那卡塞 (Ciiwealcct ) , ft学名为 N- ((LR) 1- (1-萘基)乙 基)- 3- (3- (三氟甲基》苯基)爾- 1-胺 Dmgs 2002, 27(9), 8311 83 公开了劊备 酸西那卡塞的方法, 合威路线主要如下:  The ft component of cinacalcet hydrochloride, Ciiwealcct, ft, N-((LR) 1-(1-naphthyl)ethyl)-3-(3-(trifluoromethyl) Phenyl)-l-amine Dmgs 2002, 27(9), 8311 83 discloses a method for preparing cinacalcet, and the main route is as follows:
Figure imgf000002_0001
Figure imgf000002_0001
国 P示专囊 WO2008/058235 A2公开了用 (Λ) 萘 1-基) £胺作为关键中间体的二种合成踣 线, 如下所示:  WO P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P
Figure imgf000002_0002
Figure imgf000002_0002
在 WO2008/058235 A2中公布了 (萘- 1-基)乙胺 tt制备方法, 其合成路线如卜.: The preparation method of (naphthalene-1-yl)ethylamine tt is disclosed in WO2008/058235 A2, and its synthetic route is as follows:
1 1
更正页(细则第 91条》
Figure imgf000003_0001
在此类的工艺中, (R)-l- (萘 -1-基)乙胺需要使用 (D)+萘普生来进行拆分, 将导致西那卡塞 的合成成本价格偏高。
Correction page (Article 91)
Figure imgf000003_0001
In such a process, (R)-l-(naphthalen-1-yl)ethylamine requires the use of (D) + naproxen for resolution, which will result in a higher cost of synthesis of cinacalcet.
此夕卜, Synthesis (2008), (14), 2283-2287也公布的以酶催化合成 (R)-l- (萘 -1-基)乙胺, 但存 在难于工业化的问题。  Further, Synthesis (2008), (14), 2283-2287 also discloses the enzymatic synthesis of (R)-l-(naphthalen-1-yl)ethylamine, but there is a problem that it is difficult to industrialize.
J. Org. Chem., 2013, 78 (11 ), 5314-5327也公开了一种 (R)-l - (萘 -1-基)乙胺的合成方法, 其 合成路线如下:  J. Org. Chem., 2013, 78 (11), 5314-5327 also discloses a method for synthesizing (R)-l-(naphthalen-1-yl)ethylamine, which is synthesized as follows:
Figure imgf000003_0002
Figure imgf000003_0002
在此种方法中, 需要先制备 (Z)-l ~ (萘 -1 -基)乙酮肟, 并且使用的催化剂量需要高达 15%, 使用的还原剂为四氢呋喃 -硼烷溶液, 成本较高, 不利于工业化。  In this method, it is necessary to prepare (Z)-l ~ (naphthalen-1-yl)ethanone oxime, and the amount of catalyst used needs to be as high as 15%, and the reducing agent used is a tetrahydrofuran-borane solution, which is expensive. Not conducive to industrialization.
虽然关于 (萘 - 1-基)乙胺的合成方法的报道有很多, 但都具有一定的局限性, 如产率 低、 难于实现工业化或使用的试剂价格比较高昂等。  Although there have been many reports on the synthesis of (naphthyl-1-yl)ethylamine, they all have certain limitations, such as low yield, difficulty in industrialization, or relatively high cost of reagents used.
发明内容 Summary of the invention
本发明的目的是提供一种成本低廉、 产品质量良好的新的合成 (R)-l~ (萘 -1-基)乙胺的方 法。  SUMMARY OF THE INVENTION An object of the present invention is to provide a novel process for synthesizing (R)-l~(naphthalen-1-yl)ethylamine which is inexpensive and of good product quality.
本发明为解决上述问题采用的技术方案为:  The technical solution adopted by the present invention to solve the above problems is as follows:
一种合成 (i?)-l - (萘 -1- 基)乙胺 ( I ) 的工艺, 包括以下合成路线及路线所包含的 4个 步骤:  A process for the synthesis of (i?)-l-(naphthalen-1-yl)ethylamine (I), including the following four steps involved in the synthetic route and route:
2 2
更正页(细则第 91条) Correction page (Article 91)
Figure imgf000004_0001
Figure imgf000004_0001
( 用溶剂 Β溶解无水 1-萘乙酮并通氩气鼓泡除气后, 加入与无水 1-萘乙酮的摩尔比为(The solvent is used to dissolve anhydrous 1-naphthyl ethyl ketone and degassed by argon gas, and the molar ratio to anhydrous 1-naphthylethyl ketone is
1/100 ~ 1/100000的催化剂 Α, 优选 (5, 5)-DIOPRuCl2(5)-Me-BIMAH , 加入与无水 1-萘乙酮的 摩尔比为 20/1 ~30/1的碱 C, 充入 8 ~ 30 bar氢气, 在 0 ~ 50 °C下搅拌 8-16 h; 过滤, 旋除溶 剂后得米白色固体 (萘 -1 -基)乙醇 (II); 1/100 ~ 1/100000 of catalyst Α, preferably (5, 5)-DIOPRuCl 2 (5)-Me-BIMAH, added to the base with a molar ratio of anhydrous 1-naphthyl ethyl ketone of 20/1 ~ 30/1 C, charged with 8 ~ 30 bar of hydrogen, stirred at 0 ~ 50 °C for 8-16 h; filtered, solvent was removed to give off-white solid (naphthalen-1-yl) ethanol (II);
(2) 将得到的 0)-1- (萘 -1- 基)乙醇(II), 用溶剂 D溶解后, 加入与 II的摩尔比为 5/1 ~ 1/1 的缚酸剂 E, 0~5 °C下滴加与 II的摩尔比为 10/1 ~ 1/1磺酰氯衍生物 F-溶剂 D溶液, 滴完之 后室温搅拌 l ~ 8 h; 以饱和氯化铵溶液淬灭后, 分出有机层, 水层以二氯甲烷萃取, 合并有 机相, 用无水硫酸钠干燥, 旋干得棕色油状物 (S)-l- (萘 -1-基)乙基磺酸酯衍生物 (III); (2) The obtained 0)-1-(naphthalen-1-yl)ethanol (II) is dissolved in a solvent D, and then an acid-binding agent E, 0 is added in a molar ratio of 5/1 to 1/1 with II. The molar ratio of II to 1/1/1 sulfonyl chloride derivative F-solvent D was added dropwise at ~5 °C. After the completion of the dropwise addition, the mixture was stirred at room temperature for 1-8 h ; after quenching with saturated ammonium chloride solution, The organic layer was separated, the aqueous layer was extracted with methylene chloride, and the organic phase was combined, dried over anhydrous sodium sulfate, and dried to give a brown oil (S)-l-(naphthalen-1-yl)ethyl sulfonate derivative (III);
(3)参考 Tetrahedron (1991), 47(9), 1603-1610中将磺酸酯经 SN2取代反应后转化成构型 翻转的叠氮化物的方法, 将得到的 (萘 -1 -基)乙基磺酸酯衍生物 (ΠΙ) 溶于无水溶剂 G 中, 加入与 III的摩尔比为 2/1 ~ 5/1的叠氮化物 H, 在 30 -60 °C下搅泮 8 ~ 16 h, 加水稀释 后, 以乙酸乙酯萃取, 合并有机相, 用无水硫酸钠干燥, 旋除溶剂得棕色油状物 (R)-l-(l-叠氮 基乙基)萘 (IV) ; (3) Referring to Tetrahedron (1991), 47(9), 1603-1610, a method for converting a sulfonate to a configuration-overturned azide by a SN 2 substitution reaction, which will be obtained (naphthalene-1-yl) The ethyl sulfonate derivative (ΠΙ) is dissolved in an anhydrous solvent G, and an azide H having a molar ratio of 2/1 to 5/1 is added, and the mixture is stirred at 30 to 60 ° C for 8 to 16 h, diluted with water, extracted with EtOAc, EtOAc (EtOAc)EtOAc.
(4) 将 (R)-l-(l-叠氮基乙基)萘 (IV) 以甲醇溶解后, 加入 IV的质量的 1%~ 80%的催化 剂 I氢化, 室温搅拌 16 ~ 40 h; 过滤去除催化剂, 旋除溶剂, 快速过三氧化二铝柱得黄色油 状物 (R)-l- (萘 -1- 基)乙胺 ( I )。 (4) After dissolving (R)-l-(l-azidoethyl)naphthalene (IV) in methanol, hydrogenation is carried out by adding 1% to 80% of the catalyst I of the mass of IV, and stirring at room temperature for 16-40 hours ; The catalyst was removed by filtration, the solvent was evaporated, and the alumina column was passed quickly to afford (yield: <RTIgt;
在一种实施方式中, 步骤 (1)所述的催化剂 A是由 DIOP、 BI AP Josiphos等磷配体 与中山奕安泰医药科技有限公司生产的 BIMAH配体及二氯苯基钌 (II)二聚体参考 Adv. Synth. Catal.2011, 353, 495 - 500的方法制备而来的催化剂, 优选 (<S, S)-DiopRuCl2OS)-Me-BIMAH。 In one embodiment, the catalyst A described in the step (1) is a BIMAH ligand and a dichlorophenyl ruthenium (II) complex produced by a phosphorus ligand such as DIOP, BI AP Josiphos, etc., and Zhongshan Aantai Pharmaceutical Technology Co., Ltd. The catalyst prepared by the method of Adv. Synth. Catal. 2011, 353, 495-500, preferably (<S, S)-DiopRuCl 2 OS)-Me-BIMAH.
在一种实施方式中, 步骤 (1) 所述的溶剂 B 是苯、 甲苯、 邻二甲苯、 对二甲苯、 叔丁 醇、 异丙醇、 乙醇、 甲醇、 乙腈中的任意一种或多种的混合物, 优选甲苯和叔丁醇的混合溶 剂;  In one embodiment, the solvent B in the step (1) is any one or more of benzene, toluene, o-xylene, p-xylene, tert-butanol, isopropanol, ethanol, methanol, and acetonitrile. a mixture, preferably a mixed solvent of toluene and tert-butanol;
3 3
更正页(细则第 91条) 在一种实施方式中, 步骤 (1 ) 所述的碱 C为叔丁醇钾、 叔丁醇钠、 碳酸铯、 碳酸钾、 乙醇钠、 氨基钠中的任意一种或多种的混合物, 优选叔丁醇钾。 Correction page (Article 91) In one embodiment, the base C in the step (1) is a mixture of any one or more of potassium t-butoxide, sodium t-butoxide, cesium carbonate, potassium carbonate, sodium ethoxide, and sodium amide. Potassium tert-butoxide.
在一种实施方式中, 步骤 (1 ) 所述的氢气压为 8 ~ 30 bar, 优选 30 bar。  In one embodiment, the hydrogen pressure in step (1) is 8 to 30 bar, preferably 30 bar.
在一种实施方式中, 步骤 (2)所述的溶剂 D为甲苯、 四氢呋喃、 二氯甲烷、 N, N-二甲 基甲酰胺、 氯仿中的任意一种或多种的混合物, 优选二氯甲垸。  In one embodiment, the solvent D described in the step (2) is a mixture of any one or more of toluene, tetrahydrofuran, dichloromethane, N, N-dimethylformamide, chloroform, preferably dichloro Hyperthyroidism.
在一种实施方式中, 步骤 (2) 所述的缚酸剂 E为三乙胺、 二异丙基乙胺、 吡啶、 N, N- 二甲基吡啶、 碳酸钾、 碳酸铯、 碳酸钠、 碳酸镁、 氢氧化钾、 氢氧化钠中的任意一种或多种 的混合物, 优选三乙胺。  In one embodiment, the acid binding agent E in the step (2) is triethylamine, diisopropylethylamine, pyridine, N, N-lutidine, potassium carbonate, cesium carbonate, sodium carbonate, A mixture of any one or more of magnesium carbonate, potassium hydroxide and sodium hydroxide is preferably triethylamine.
在一种实施方式中, 步骤 (2) 所述的磺酰氯衍生物 F为甲基磺酰氯、 三氟甲基磺酰氯、 对甲苯磺酰氯、 苯磺酰氯中的任意一种或多种的混合物, 优选甲基磺酰氯。  In one embodiment, the sulfonyl chloride derivative F according to the step (2) is a mixture of any one or more of methylsulfonyl chloride, trifluoromethylsulfonyl chloride, p-toluenesulfonyl chloride, and benzenesulfonyl chloride. Preferably, methylsulfonyl chloride is used.
在一种实施方式中, 步骤 (2) 所述的 (5)-1- (萘 -1-基)乙醇 (II) 与磺酰氯衍生物 F的投 料比为 1/1 ~ 1/10, 优选 1/1.5。  In one embodiment, the ratio of the (5)-1-(naphthalen-1-yl)ethanol (II) to the sulfonyl chloride derivative F in the step (2) is from 1/1 to 1/10, preferably. 1/1.5.
在一种实施方式中, 步骤.(3 ) 所述的无水溶剂 G为二甲基亚砜、 N, N-二甲基甲酰胺、 丙酮、 氮甲基吡咯垸酮、 四氢呋喃、 乙腈中的任意一种或多种的混合物, 优选二甲基亚砜。  In one embodiment, the anhydrous solvent G in the step (3) is dimethyl sulfoxide, N, N-dimethylformamide, acetone, nitromethylpyrrolidone, tetrahydrofuran, acetonitrile. Mixture of any one or more, preferably dimethyl sulfoxide.
在一种实施方式中, 步骤 (3 ) 所述的叠氮化物 H为叠氮化钠、 叠氮化锂、 叠氮化钾、 叠氮磷酸二苯酯中的任意一种或多种的混合物, 优选叠氮化钠。  In one embodiment, the azide H of the step (3) is a mixture of any one or more of sodium azide, lithium azide, potassium azide, and diphenyl azide. , sodium azide is preferred.
在一种实施方式中,步骤 (4)所述的催化剂 I为含钯催化剂或含镍催化剂,其为 20%Pd/C、 10% Pd/C、 5% Pd/C、 10% Pd(OH)2/C、 20% Pd(OH)2/C 雷尼镍中的任意一种或多种的混合 物, 优选 10% Pd/C。 In one embodiment, the catalyst I described in the step (4) is a palladium-containing catalyst or a nickel-containing catalyst, which is 20% Pd/C, 10% Pd/C, 5% Pd/C, 10% Pd (OH). A mixture of any one or more of 2 / C, 20% Pd(OH) 2 /C Raney nickel, preferably 10% Pd/C.
本发明提供的方法具有的显著优点:  The method provided by the present invention has significant advantages:
1、 与传统的拆分工艺方法相比, 避免了拆分步骤, 避免浪费, 成本更低。  1. Compared with the traditional splitting process, the splitting step is avoided, waste is avoided, and the cost is lower.
2、 工艺路线操作简单, 工艺容易实现工业化。  2. The process route is simple to operate and the process is easy to realize industrialization.
具体实 I»式 Concrete I»
下面结合实施例对本发明作进一步说明。 但本发明的保护范围不能认为仅局限于下述具 体实施方式。 在不脱离本发明基本构思的前提下, 所属领域的技术人员据此作出的简单推演 或同等替换方案, 均属于本发明的保护范围。  The invention is further illustrated by the following examples. However, the scope of protection of the present invention is not considered to be limited to the specific embodiments described below. The simple derivation or equivalent alternatives made by those skilled in the art without departing from the basic idea of the invention are all within the scope of the invention.
实施例 1 Example 1
( 1 ) 在 250 mL干燥的史莱克瓶中, 1.70 g C lO mmol) 的无水 1-萘乙酮以 30 mL无水甲  (1) In a 250 mL dry Shrek bottle, 1.70 g C lO mmol) of anhydrous 1-naphthylacetone with 30 mL of anhydrous A
更正页(细则第 91条) 苯溶解,通氩气鼓泡 15 min后,转移至 100 mL的氢化管中,加入 10 mg的 (& 5)-Diop-RuCl2-(5)- Me-BIMAH催化剂和 70 mg (0.6 mmol) 的叔丁醇钾, 通入 30 bar的氢气, 在 25。C下搅拌 16 ho过滤,旋除溶剂,得浅黄色油状物 0S)-1- (萘 -1-基)乙醇,久置后为固体,转化率为 99.2%, ee值为 98%, 无需纯化, 直接进行下一步反应。 Correction page (Article 91) The benzene was dissolved, argon gas was bubbled for 15 min, transferred to a 100 mL hydrogenation tube, and 10 mg of (& 5)-Diop-RuCl 2 -(5)-Me-BIMAH catalyst and 70 mg (0.6 mmol) were added. Potassium tert-butoxide, fed to 30 bar of hydrogen, at 25. After stirring for 16 ho, the solvent was evaporated to give a pale-yellow oil (0S)-1-(naphthalen-1-yl)ethanol, which was solid after a long period of time, the conversion was 99.2%, and the ee value was 98% without purification. , proceed directly to the next step.
(2) 将 1.72 g (10 mmol)的 (萘 -1-基)乙醇以 20 mL的二氯甲垸溶解后转移至〗00 mL 的三口烧瓶中, 加入 4.0mL(30mmol)的三乙胺, 0 °C下滴加 1.16 mL溶解于 10 mL二氯甲垸 的甲基磺酰氯溶液, 滴加完毕后转升温至 25 °C搅拌 4 h。 加入 100 mL的饱和氯化铵溶液淬 灭, 分出有机层, 水层以二氯甲垸萃取 (30 mL x 3), 合并有机相, 无水硫酸钠干燥, 旋除 溶剂得浅黄色油状物 2.41 g, 收率 96.4%。  (2) Dissolve 1.72 g (10 mmol) of (naphthalen-1-yl)ethanol in 20 mL of dichloromethane, transfer to a 00 mL three-necked flask, and add 4.0 mL (30 mmol) of triethylamine. At 0 °C, 1.16 mL of methylsulfonyl chloride solution dissolved in 10 mL of dichloromethane was added dropwise. After the addition was completed, the temperature was raised to 25 ° C and stirred for 4 h. After quenching with 100 mL of a saturated aqueous solution of ammonium chloride, the organic layer was separated, and the aqueous layer was extracted with methylene chloride (30 mL x 3). The organic phase was combined and dried over anhydrous sodium sulfate. 2.41 g, yield 96.4%.
(3) 将步骤(2)中得到的 1.258(5.011^101)的(5)-1-(萘-1-基)乙基甲基磺酸酯以 15 mL 的无水二甲基亚砜溶解后, 加入 0.65 g (10 mmol) 的叠氮化钠, 于 60°C下搅拌 12h。 加入 150 mL的纯净水后, 以乙酸乙酯萃取 (50mLx 3), 合并有机相, 无水硫酸钠干燥, 旋除溶 剂得 0.89 g浅黄色油状物, 收率 90.4%。 (3) 1.25 8 (5.011^1 0 1) of (5)-1-(naphthalen-1-yl)ethyl methanesulfonate obtained in the step (2) as 15 mL of anhydrous dimethyl After the sulfoxide was dissolved, 0.65 g (10 mmol) of sodium azide was added, and the mixture was stirred at 60 ° C for 12 h. After adding 150 mL of purified water, ethyl acetate (50 mL×3) was combined, and the organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was evaporated to give a pale yellow oil (yield: 90.4%).
(4) 在 50 mL的氢化管中, 将步骤 (3) 得到的 0.8 g浅黄色油状物以 20 mL的甲醇溶 解后, 加入 80mg的 10%Pd/C, 充入 1 bar的氢气, 25 °C搅拌 24 h。 过滤, 旋除溶剂得浅黄 色油状物, 快速过碱性三氧化二铝柱得 0.62 g黄色油状物, 收率 89%, ee值为 94%。  (4) In a 50 mL hydrogenation tube, dissolve 0.8 g of light yellow oil obtained in step (3) in 20 mL of methanol, add 80 mg of 10% Pd/C, and charge 1 bar of hydrogen, 25 °. C is stirred for 24 h. Filtration, the solvent was evaporated to give a pale yellow oil, and a crude over-alloyed alumina column yielded 0.62 g of a yellow oil with a yield of 89% and an ee value of 94%.
实施例 2 Example 2
(1)在 250 mL干燥的史莱克瓶中, 1.70 g (10 mmol) 的无水 1-萘乙酮以 30 mL无水甲 苯溶解,通氩气鼓泡 15 min后,转移至 100 mL的氢化管中,加入 11 mg的 5)-Diop-RuCl2-(5)- i-Pr-BIMAH催化剂和 70 mg (0.6 mmol) 的叔丁醇钾, 通入 30 bar的氢气, 在 25 °C下搅拌 16 h„过滤,旋除溶剂,得浅黄色油状物 (5)-1- (萘 -1-基)乙醇,久置后为固体,转化率为 98.2%, ee值为 95%, 无需纯化, 直接进行下一步反应。' (1) In a 250 mL dry Shrek bottle, 1.70 g (10 mmol) of anhydrous 1-naphthylacetone was dissolved in 30 mL of anhydrous toluene, argon gas was bubbled for 15 min, and transferred to 100 mL of hydrogenated solution. In the tube, add 11 mg of 5)-Diop-RuCl 2 -(5)-i-Pr-BIMAH catalyst and 70 mg (0.6 mmol) of potassium t-butoxide, and pass 30 bar of hydrogen at 25 °C. After stirring for 16 h „filtering, the solvent was evaporated to give a pale yellow oil (5)-1-(naphthalen-1-yl)ethanol, which was solid after a long period of time, the conversion was 98.2%, and the ee value was 95% without purification. , proceed directly to the next step.'
(2)将 1.72 g (10 mmol)的 (5)- (萘 -1-基)乙醇以 20 mL的四氢呋喃溶解后转移至 100 mL 的三口烧瓶中,加入 2.4mL(30mmol)的吡啶, 0。C下滴加 1.16 mL溶解于 10 mL四氢呋喃的 甲基磺酰氯溶液, 滴加完毕后转升温至 25 °C搅拌 4 h。加入 100 mL的饱和氯化铵溶液淬灭, 静置分层, 水层以二氯甲垸萃取 (30 mL x 3), 合并有机相, 无水硫酸钠干燥, 旋除溶剂得 浅黄色油状物 2.35 g, 收率 94%。  (2) 1.72 g (10 mmol) of (5)-(naphthalen-1-yl)ethanol was dissolved in 20 mL of tetrahydrofuran, transferred to a 100 mL three-necked flask, and 2.4 mL (30 mmol) of pyridine, 0 was added. 1.16 mL of methylsulfonyl chloride solution dissolved in 10 mL of tetrahydrofuran was added dropwise to C, and the mixture was heated to 25 ° C for 4 h. After quenching with 100 mL of saturated ammonium chloride solution, the mixture was separated and the layers were separated. The aqueous layer was extracted with methylene chloride (30 mL x 3), and the organic phase was combined and dried over anhydrous sodium sulfate. 2.35 g, yield 94%.
(3) 将步骤(2)中得到的 1.25§(5.0皿01)的(5)-1-(萘-1-基)乙基甲基磺酸酯以 15 mL 的无水 Ν,Ν-二甲基甲酰胺溶解后,加入 0.49 g( 10 mmol)的叠氮化锂,于 60 °C下搅拌 12h。 (3) 1.25 § (5.0 dish 01) of (5)-1-(naphthalen-1-yl)ethyl methanesulfonate obtained in step (2) with 15 mL of anhydrous hydrazine, Ν-II After the methylformamide was dissolved, 0.49 g (10 mmol) of lithium azide was added and stirred at 60 ° C for 12 h.
5  5
更正页(细则第 91条) 加入 150 mL的纯净水后, 以乙酸乙酯萃取 (50mLx 3), 合并有机相, 无水硫酸钠干燥, 旋 除溶剂得 0.82 g浅黄色油状物, 收率 83.3%。 Correction page (Article 91) After adding 150 mL of purified water, ethyl acetate (50 mL×3) was combined, and the organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was evaporated to give a pale yellow oil (yield: 83.3%).
(4) 在 50 mL的氢化管中, 将步骤 (3) 得到的 0.8 g浅黄色油状物以 20 mL的甲醇溶 解后, 加入 80 mg的 10%PdCOH;)2/C, 充入 1 bar的氢气, 25 °C搅拌 24 h。 过滤, 旋除溶剂得 浅黄色油状物, 快速过碱性三氧化二铝柱得 0.0.59 g黄色油状物, 收率 84.7%, ee值为 92%。 实施例 3 (4) In a 50 mL hydrogenation tube, dissolve 0.8 g of light yellow oil obtained in step (3) in 20 mL of methanol, add 80 mg of 10% PdCOH;) 2 / C, and fill with 1 bar Hydrogen was stirred at 25 ° C for 24 h. Filtration, the solvent was evaporated to give a pale-yellow oil, and a crude over-alloyed alumina column yielded 0.0.59 g of a yellow oil with a yield of 84.7% and an ee value of 92%. Example 3
(1) 在 250 mL干燥的史莱克瓶中, 1.70g (lOmmol) 的无水 1-萘乙酮以 30 mL无水邻 二甲苯溶解, 通氩气鼓泡 15 min 后, 转移至 100 mL 的氢化管中, 加入 10 mg 的 5)-Diop-RuCl2-(5)- i-Bu-BIMAH催化剂和 70 mg (0.6 mmol)的叔丁醇钠,通入 30 bar的氢气, 在 25°C下搅拌 16h。 过滤, 旋除溶剂, 得浅黄色油状物 ( -1- (萘 -1-基)乙醇, 久置后为固体, 转化率为 97.3%, ee值为 94%, 无需纯化, 直接进行下一步反应。 (1) In a 250 mL dry Shrek bottle, 1.70 g (10 mmol) of anhydrous 1-naphthylacetone was dissolved in 30 mL of anhydrous o-xylene, and argon gas was bubbled for 15 min, then transferred to 100 mL. In the hydrogenation tube, 10 mg of 5)-Diop-RuCl 2 -(5)- i-Bu-BIMAH catalyst and 70 mg (0.6 mmol) of sodium t-butoxide were added, and 30 bar of hydrogen was introduced at 25 ° C. Stir under 16h. Filtration and solvent removal gave a pale yellow oil ( -1-(naphthalen-1-yl)ethanol as a solid after a long time. The conversion was 97.3%, and the ee value was 94%. .
(2) 将 1.72g(10mmol)的(Λ)-l-(萘-l-基)乙醇以20mL的二氯甲烷溶解后转移至 100 mL 的三口烧瓶中, 加入 1.68 g (30 mmol)的氢氧化钾, 0 °C下滴加 1.16 mL溶解于 10 mL二氯甲 烷的甲基磺酰氯溶液, 滴加完毕后转升温至 25 °C搅拌 4 h。 加入 100 mL的饱和氯化铵溶液 淬灭, 分出有机层, 水层以二氯甲烷萃取 (30 mL x 3), 合并有机相, 无水硫酸钠干燥, 旋 除溶剂得浅黄色油状物 2.21 g, 收率 88.4%。  (2) 1.72 g (10 mmol) of (Λ)-l-(naphthalene-l-yl)ethanol was dissolved in 20 mL of dichloromethane, transferred to a 100 mL three-necked flask, and 1.68 g (30 mmol) of hydrogen was added. Potassium oxide, 1.16 mL of methylsulfonyl chloride solution dissolved in 10 mL of dichloromethane was added dropwise at 0 °C. After the addition was completed, the temperature was raised to 25 ° C and stirred for 4 h. The organic layer was extracted with aq. g, yield 88.4%.
(3) 将步骤(2)中得到的 1.25g(5.0mmol)的 (5)-1- (萘 -1-基)乙基甲基磺酸酯以 15 mL 的无水四氢呋喃溶解后, 加入 0.81 g (10 mmol)的叠氮化钾, 于 60 °C下搅拌 12 h。加入 150 mL的纯净水后, 以乙酸乙酯萃取 (50mLx 3), 合并有机相, 无水硫酸钠干燥, 旋除溶剂得 0.85 g浅黄色油状物, 收率 86.3%。  (3) After dissolving 1.25 g (5.0 mmol) of (5)-1-(naphthalen-1-yl)ethyl methanesulfonate obtained in the step (2) in 15 mL of anhydrous tetrahydrofuran, 0.81 was added. G (10 mmol) of potassium azide was stirred at 60 ° C for 12 h. After adding 150 mL of purified water, ethyl acetate (50 mL×3) was combined, and the organic phase was combined, dried over anhydrous sodium sulfate, and the solvent was evaporated to give a pale yellow oil (yield: 86.3%).
(4) 在 50 mL的氢化管中, 将步骤 (3) 得到的 0.8 g浅黄色油状物以 20 mL的甲醇溶 解后, 加入 70 mg的 20%, 充入 1 bar的氢气, 25 °C搅拌 24 h。 过滤, 旋除溶剂得浅黄色油 状物, 快速过碱性三氧化二铝柱得 0.56 g黄色油状物, 收率 80.4%, ee值为 93%。  (4) In a 50 mL hydrogenation tube, dissolve 0.8 g of light yellow oil obtained in step (3) in 20 mL of methanol, add 70 mg of 20%, charge 1 bar of hydrogen, and stir at 25 °C. 24 h. Filtration, the solvent was evaporated to give a pale-yellow oil, and a crude over-alloyed alumina column yielded 0.56 g of a yellow oil with a yield of 80.4% and an ee value of 93%.
¾i例 4  3⁄4i example 4
(1) 在 250 mL干燥的史莱克瓶中, 1.70g (10 mmol) 的无水 1-萘乙酮以 30 mL无水叔 丁醇溶解, 通氩气鼓泡 15 min 后, 转移至 100 mL 的氢化管中, 加入 10 mg 的 5 Diop-RuCl2-(5 Me-BIMAH催化剂和 70 mg (0.6 mmol) 的叔丁醇钾, 通入 30 bar的氢气, 在 25°C下搅拌 16h。 过滤, 旋除溶剂, 得浅黄色油状物 ( -1- (萘 -1-基)乙醇, 久置后为固体, 转化率为 99.6%, ee值为 96%, 无需纯化, 直接进行下一步反应。 (2) 将 1.72 g (10 mmol)的 (Λ)-1- (萘 -1-基)乙醇以 20 mL的氯仿溶解后转移至 100 mL的 三口烧瓶中, 加入 9.8 g(30mmol)的碳酸铯, 0 °C下滴加 1.16 mL溶解于 10 mL氯仿的甲基 磺酰氯溶液, 滴加完毕后转升温至 25 °C搅拌 4 h。 加入 100 mL的饱和氯化铵溶液淬灭, 分 出有机层, 水层以二氯甲烷萃取 (30 mL x 3), 合并有机相, 无水硫酸钠干燥, 旋除溶剂得 浅黄色油状物 2.15 g, 收率 86%。 (1) In a 250 mL dry Shrek bottle, 1.70 g (10 mmol) of anhydrous 1-naphthylacetone was dissolved in 30 mL of anhydrous tert-butanol, argon gas was bubbled for 15 min, and transferred to 100 mL. In a hydrogenation tube, 10 mg of 5 Diop-RuCl 2 -(5 Me-BIMAH catalyst and 70 mg (0.6 mmol) of potassium t-butoxide were added, 30 bar of hydrogen was introduced, and the mixture was stirred at 25 ° C for 16 h. The solvent was evaporated to give a pale yellow oil ( -1-(naphthalen-1-yl)ethanol, which was solid after a long period of time. The conversion was 99.6%, and the ee value was 96%, and the next reaction was carried out without purification. (2) Dissolve 1.72 g (10 mmol) of (Λ)-1-(naphthalen-1-yl)ethanol in 20 mL of chloroform, transfer to a 100 mL three-necked flask, and add 9.8 g (30 mmol) of cesium carbonate. At 0 °C, 1.16 mL of methylsulfonyl chloride solution dissolved in 10 mL of chloroform was added dropwise. After the addition was completed, the temperature was raised to 25 ° C and stirred for 4 h. The organic layer was extracted with aq. g, yield 86%.
(3) 将步骤(2)中得到的 1.25g(5.0mmol)的 (5)-1- (萘 -1-基)乙基甲基磺酸酯以 15 mL 的无水二甲基亚砜溶解后, 加入 0.65 g (lOmmol) 的叠氮化钠, 于 60 °C下搅拌 12 h。 加入 150 mL的纯净水后, 以乙酸乙酯萃取 (50mLx 3), 合并有机相, 无水硫酸钠干燥, 旋除溶 剂得 0.89 g浅黄色油状物, 收率 90.4%。  (3) 1.25 g (5.0 mmol) of (5)-1-(naphthalen-1-yl)ethyl methanesulfonate obtained in the step (2) was dissolved in 15 mL of anhydrous dimethyl sulfoxide. Thereafter, 0.65 g (10 mmol) of sodium azide was added, and the mixture was stirred at 60 ° C for 12 h. After adding 150 mL of purified water, it was extracted with ethyl acetate (50 mL×3), and the organic phase was combined, dried over anhydrous sodium sulfate, and then evaporated to give a solvent.
(4) 在 50 mL的氢化管中, 将步骤 (3) 得到的 0.8 g浅黄色油状物以 20 mL的甲醇溶 解后, 加入 60 mg的雷尼镍, 充入 1 bar的氢气, 25 °C搅拌 24 h。 过滤, 旋除溶剂得浅黄色 油状物, 快速过碱性三氧化二铝柱得 0.65 g黄色油状物, 收率 93.3%, ee值为 94%。  (4) Dissolve 0.8 g of light yellow oil obtained in step (3) in 20 mL of methanol in a 50 mL hydrogenation tube, add 60 mg of Raney nickel, and charge 1 bar of hydrogen at 25 °C. Stir for 24 h. Filtration, the solvent was evaporated to give a pale-yellow oil, and the crude over-alloyed alumina column yielded 0.65 g of a yellow oil with a yield of 93.3% and an ee value of 94%.

Claims

极麵 要求书 Polar face request
1、 —种合戚(Λ)小 (萘小基)乙胺 ( I ) 的工艺, 其特征在于, 所逮 »工艺包 以下合成賂 线及路线所包含《4个 :  1. A process for combining (小) small (naphthalene small base) ethylamine (I), which is characterized by the following: "Technology package" The following synthetic lines and routes contain "4:
Figure imgf000009_0001
Figure imgf000009_0001
(1》用涛剂 B溶解无水 1靈乙酮并通氩气鼓應 ft气后,加入与无 * 1-蔡乙酮 tt摩尔比为 1/100 (1) Dissolve water with Tao agent B. 1 Ethyl ketone and argon gas should be ft gas, add and no * 1-Cai ethyl ketone tt molar ratio is 1/100
- 1/100000謝崔化麵 A, 加入与无水 1-萘乙丽 »摩尔 tt* 20/1 -30/1 tt碱 C, 売入 8 ~ 30 bar 氢气, 在 ~50 C下擁拌 846 过滤, 旋除溶剂后得米白色園 -1- (萘 -1-基)乙醇(II);- 1/100000 Xie Cuihua No. A, added with anhydrous 1-naphthyl ate»mol tt* 20/1 -30/1 tt base C, infused with 8 ~ 30 bar hydrogen, mixed at ~50 C 846 Filtration, the solvent is removed to obtain the rice white-1-(naphthalen-1-yl)ethanol (II);
(2)将得到 萘 -1-基)乙醇 (Π), 用清舰 D涛鮮后》 加入与 II ft扉尔 tfc为 5/1〜 1/1的 缚酸割 E, 0 5eC下滴加与 II的摩尔 tt为 /1 1/1磺酰氯衍生物 F涛割 D溶液, 滴完之后 室 s繼 #i ~§h; a饱 m氯 ft僚灌液諄灭后, ¾有机层, 水层 a二氯甲烷萃取, 合并有机 相 用无水硫酸钠千燥, 旋干得棕色油状物 (5)- 1霍 基)乙基礒酸酯 ft生物復 1); (2) will get naphthalen-1-yl)ethanol (Π), after clearing the ship D Tao fresh" added with II ft 扉 t tfc for 5 / 1 ~ 1 / 1 binding acid cut E, 0 5 e C Add dropwise to the molar tt of II is /1 1 / 1 sulfonyl chloride derivative F Taotao D solution, after the completion of the drop chamber s following #i ~ § h ; a saturated m chloro ft 僚 谆 谆 ,, 3⁄4 organic layer The aqueous layer is extracted with methylene chloride, and the organic phase is combined with anhydrous sodium sulfate to dryness, and then dried to give a brown oil (5)-1 (Hocchi) ethyl phthalate ft biological complex 1) ;
(3)将得到 (萘 4 ·基)乙基磺酸酯衍生物(ΠΙ)溶于无水溶剂 G中, 加入与 III «摩尔 比为 2/1〜 5/1 叠氣 ft物 H, 在 3040eC下撹捧 8 ½h» 加*稀释后, 以乙黢乙酯萃取, 合弁有机相, 用无水硫酸钠干燥, 旋隱清剂得 H色油状物 (Λ)-Ι-(Ι-叠氮基乙基)蔡 (IV);(3) The (naphthalene 4 · yl) ethyl sulfonate derivative (ΠΙ) is dissolved in an anhydrous solvent G, and is added to a mixture with III « molar ratio of 2/1 to 5/1. After 3040 e C, the mixture is diluted with 8 1⁄2h» plus *, extracted with ethyl acetate, combined with organic phase, dried over anhydrous sodium sulfate, and clarified to obtain H color oil (Λ)-Ι-(Ι- Azidoethyl)cai(IV);
(4)梅 小 (1-叠氮基乙基)萘藝 甲醇溶解后, 加入 IV»廣量的 1%~隱¾ 催化麵 I氛 化,窒温擢持 16~40h5 «滤去隱催化割》旋除溶剂,快¾过三氧化二铝柱得黄色油状物 1»(4) After dissolving the small (1-azidoethyl)naphthalene methanol, add IV» extensive amount of 1%~ hidden 3⁄4 catalytic surface I to liquefy, and hold the temperature for 16~40h 5 «Filtering hidden catalysis Cut off the solvent, quickly 3⁄4 through the alumina column to get a yellow oil 1»
(蔡小基)乙胺 ( I )» (Cai Xiaoji) Ethylamine ( I )»
2、 ft据极利要求 1 翁工艺, 其特 在于所述催 剂 A为膦配 #与÷山 安泰医药科 tt 有隱 司生产 ft B1MAH配体及二氯苯基钌 (II) 二聚体制备而来的催化剂。  2, ft according to the extremely demanding 1 Weng process, the special is that the catalyst A is phosphine with # and ÷山安泰医科 tt has a secret division to produce ft B1MAH ligand and dichlorophenyl ruthenium (II) dimer Prepared catalyst.
3、 根据权利要求 1所述的工艺, 其特征在于 達 清剂 B是苯、 甲苯、 邻二甲苯、 对二甲 苯、 闻二甲苯、 正己垸、 环己烷、 叔丁醇、 乙醇、 甲醇、 乙腈中的任意一种或多种 漏合物》 3. The process of claim 1 wherein the clearing agent B is benzene, toluene, o-xylene, p-xylene, xylene, n-hexane, cyclohexane, tert-butanol, ethanol, methanol, Any one or more of the leaking compounds in acetonitrile
4、 棍据概利要求 1所述的工艺, 其特征在于所達碱 C为叙丁醇娜、 叔丁醇销、 碳酸艳、 碳 黢钾、 乙醇輸、 氨基钠 Φ的任意一种或多种的濕合物 4. The process according to claim 1, wherein the alkali C is any one or more of sodium butoxide, tert-butanol, carbonate, carbon hydride, ethanol, and sodium Φ. Wet compound
5、 棍鋸权利要求 1 達的工艺, 其特征在于廣逮 tt清劃 D为甲苯、 四氢呋喃、 二氯甲垸、 N,N-:¥基甲酰胺、 氣仿申 任意一种或多种 »«舍物《>  5, the bar saw claim 1 to the process, which is characterized by the wide catch tt clear D as toluene, tetrahydrofuran, methylene chloride, N, N-: carbamide, gas imitation any one or more » «舍物》>
8  8
更正页(细则第 91条) Correction page (Article 91)
6、根据权利要求 1所述的工艺,其特征在于所述的缚酸剂 E为三乙胺、二异丙基乙胺、吡啶、 N,N-二甲基吡啶、 碳酸钾、 碳酸铯、 碳酸钠、 碳酸镁、 氢氧化钾、 氢氧化钠中的任意一种或 多种的混合物。 6. The process of claim 1 wherein said acid scavenger E is triethylamine, diisopropylethylamine, pyridine, N,N-lutidine, potassium carbonate, cesium carbonate, a mixture of any one or more of sodium carbonate, magnesium carbonate, potassium hydroxide, and sodium hydroxide.
7、根据权利要求 1所述的工艺, 其特征在于所述的磺酰氯衍生物 F为甲基磺酰氯、三氟甲基 磺酰氯、 对甲苯磺酰氯、 苯磺酰氯中的任意一种或多种的混合物。  The process according to claim 1, wherein the sulfonyl chloride derivative F is any one or more of methylsulfonyl chloride, trifluoromethylsulfonyl chloride, p-toluenesulfonyl chloride, and benzenesulfonyl chloride. Kind of mixture.
8、 根据权利要求 1所述的工艺, 其特征在于所述的无水溶剂 G为二甲基亚砜、 N, N-二甲基 甲酰胺、 丙酮、 四氢呋喃中的任意一种或多种的混合物。  8. The process according to claim 1, wherein the anhydrous solvent G is any one or more of dimethyl sulfoxide, N, N-dimethylformamide, acetone, and tetrahydrofuran. mixture.
9、 根据权利要求 1所述的工艺, 其特征在于所述的叠氮化物 H为叠氮化钠、 叠氮化锂、 叠 氮化钾、 叠氮磷酸二苯酯中的任意一种或多种的混合物。  9. The process of claim 1 wherein said azide H is any one or more of sodium azide, lithium azide, potassium azide, and diphenyl azide. Kind of mixture.
10、 根据权利要求 1所述的工艺, 其特征在于所述催化剂 I为含钯催化剂或含镍催化剂, 其 为 20%Pd/C、 10% Pd/C、 5% Pd/C、 10%Pd(OH)2/C、 20%Pd(OH)2/C、 雷尼镍中的任意一种或 多种的混合物。 10. The process of claim 1 wherein said catalyst I is a palladium-containing catalyst or a nickel-containing catalyst which is 20% Pd/C, 10% Pd/C, 5% Pd/C, 10% Pd. A mixture of any one or more of (OH) 2 /C, 20% Pd(OH) 2 /C, Raney nickel.
9 9
更正页(细则第 91条)  Correction page (Article 91)
PCT/CN2014/082413 2014-06-18 2014-07-17 Process for synthesizing (r)-1-(naphthalene-1-group) ethylamine WO2015192433A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410274431.7A CN104045568A (en) 2014-06-18 2014-06-18 Novel process for synthesizing (R)-1-(naphthalene-1-yl) ethylamine
CN201410274431.7 2014-06-18

Publications (1)

Publication Number Publication Date
WO2015192433A1 true WO2015192433A1 (en) 2015-12-23

Family

ID=51499013

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2014/082413 WO2015192433A1 (en) 2014-06-18 2014-07-17 Process for synthesizing (r)-1-(naphthalene-1-group) ethylamine

Country Status (2)

Country Link
CN (1) CN104045568A (en)
WO (1) WO2015192433A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111574323B (en) * 2020-06-09 2023-03-28 中山奕安泰医药科技有限公司 Preparation method of R-1- (naphthalene-1-yl) ethanol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1143634A (en) * 1996-06-25 1997-02-26 厦门大学 Stereoselective synthesizing process for enantiomorph pure 3-amino-1,2-twice substituted pyrrolidine
CN1660829A (en) * 2004-12-21 2005-08-31 厦门大学 Method for synthesizing (R)-3-amido tetrahydrofuran
CN102417523A (en) * 2010-09-27 2012-04-18 中山奕安泰医药科技有限公司 Nitrogen heterocycle ligand transition metal complex, and preparation and catalytic application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
DE122005000033I2 (en) * 1994-10-21 2006-11-23 Nps Pharma Inc Calcium receptor active compounds
EP1824868B1 (en) * 2004-11-11 2010-06-02 DSM IP Assets B.V. Chiral compound suitable as a catalyst for asymmetric transfer hydrogenation
WO2008058236A2 (en) * 2006-11-08 2008-05-15 Dr. Reddy's Labortories, Ltd. Methods for preparing cinacalcet hydrochloride
CN102863554A (en) * 2012-09-21 2013-01-09 中国科学院烟台海岸带研究所 6-amino-6-deoxy chitin and preparation thereof
CN103420845B (en) * 2013-08-21 2015-09-02 中国药科大学 One prepares the method for cinacalcet intermediate R-(+)-1-(1-naphthyl) ethamine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1143634A (en) * 1996-06-25 1997-02-26 厦门大学 Stereoselective synthesizing process for enantiomorph pure 3-amino-1,2-twice substituted pyrrolidine
CN1660829A (en) * 2004-12-21 2005-08-31 厦门大学 Method for synthesizing (R)-3-amido tetrahydrofuran
CN102417523A (en) * 2010-09-27 2012-04-18 中山奕安泰医药科技有限公司 Nitrogen heterocycle ligand transition metal complex, and preparation and catalytic application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OU, WENHUA ET AL.: "Asymmetric Synthesis of Nonracemic Primary Amines via Spiroborate-Catalyzed Reduction of Pure (E)-and (Z) O Benzyloximes: Applications toward the Synthesis of Calcimimetic Agents", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 78, 2 May 2013 (2013-05-02), pages 5314 - 5327, XP055244202 *

Also Published As

Publication number Publication date
CN104045568A (en) 2014-09-17

Similar Documents

Publication Publication Date Title
Cao et al. Sequential Au (I)/chiral tertiary amine catalysis: a tandem C–H functionalization of anisoles or a thiophene/asymmetric Michael addition sequence to quaternary oxindoles
Bera et al. Cobalt (III)‐Catalyzed Construction of Benzofurans, Benzofuranones and One‐Pot Orthogonal C− H Functionalizations to Access Polysubstituted Benzofurans
CN102225915B (en) Chiral oxazoline and synthesis method thereof
US8962898B2 (en) Optically active ammonium salt compound, production intermediate thereof, and production method thereof
Sable et al. Carbon dioxide based methodologies for the synthesis of fine chemicals
TW200925141A (en) New process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and application in the synthesis of agomelatine
Yang et al. Iron-catalyzed alkylation of α-oxo ketene dithioacetals
Zhao et al. Pd/GF-Phos-catalyzed asymmetric three-component coupling reaction to access chiral diarylmethyl alkynes
Li et al. Multicomponent formation of fused pyrroles through p-TsOH promoted N-arylation
Xie et al. Cp* Ir (iii)-and Cp* Rh (iii)-catalyzed C (sp 2)–H amination of arenes using thioethers as directing groups
Miura et al. Direct asymmetric aldol reactions in water with a β-aminosulfonamide organocatalyst
TW201527288A (en) Methods of producing alkylfurans
JP5234901B2 (en) Method for producing asymmetric catalyst Michael reaction product
Luo et al. pH-Mediated Selective Synthesis of N-Allylic Alkylation or N-Alkylation Amines with Allylic Alcohols via an Iridium Catalyst in Water
Liu et al. Regio-and stereoselective synthesis of 2-cyclopentenones via a hydrogenolysis-terminated Heck cyclization of β-alkylthio dienones
WO2015192433A1 (en) Process for synthesizing (r)-1-(naphthalene-1-group) ethylamine
WO2014005546A1 (en) Preparation method of tapentadol hydrochloride and compounds for preparation of tapentadol hydrochloride
Liu et al. An efficient and straightforward approach for accessing thionoesters via palladium-catalyzed C–N cleavage of thioamides
CN103596917B (en) The manufacture method of cyclopentanone compound and midbody compound
TW201035028A (en) Process for the preparation of optically active compounds using transfer hydrogenation
Lu et al. Primary-secondary diamines catalyzed Michael reaction to generate chiral fluorinated quaternary carbon centers
Jung et al. Total synthesis of rodgersinol: a survey of the Cu (II)-mediated coupling of ortho-substituted phenols
CN106187825A (en) A kind of N, N diamides base replaces hydazone derivative and synthetic method
Chen et al. Nickel-catalyzed enantioselective domino Heck/Sonogashira coupling for construction of C (sp)-C (sp3) bond-substituted quaternary carbon centers
WO2014073003A1 (en) Single-step process for the preparation of aryl olefins

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14895109

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14895109

Country of ref document: EP

Kind code of ref document: A1